The global biologics market size is expected to reach USD 1,009.37 billion by 2030. The market is expected to expand at a CAGR of 10.3% from 2023 to 2030. Increasing burden of cancer, neurological diseases, genetic diseases and autoimmune diseases and approval of novel biologic drugs such as gene therapy, RNAi therapeutics, and antibody-drug conjugates are a few factors driving the biologics market. ![Global Biologics Market]( "Global Biologics Market")
As of 2022, there were already 27 cell and gene therapy drugs approved in the U. S., with five of them receiving approval that year. Sarepta’s gene therapy SRP-9001, which is currently in phase 3 trials for the treatment of duchenne muscular dystrophy has a PDUFA date set for May 29, 2023. Other potential gene therapy candidates in the pipeline include Krystal Biotech’s Beremagene geperpavec (B-VEC) for dystrophic epidermolysis bullosa; UniQure’s AMT-130 for Huntington disease; Intellia’s NTLA-2001 and NTLA-2002 for transthyretin (ATTR) amyloidosis; Nanoscope’s MCO-010 and Pfizer’s Fidanacogene elaparvovec for hemophilia B. The approval and subsequent commercialization of these gene therapy candidates are expected to drive growth in the biologics market.
Monoclonal antibodies account for the largest number of biologics approved. While the approval of traditional monoclonal antibodies has slowed down, next-generation antibodies such a bispecific-monoclonal antibodies, antibody fragments, radio-immunotherapies, nanobodies, and antibody-drug conjugates is driving the growth of this segment. For instance, in September 2021, the U. S. FDA approved Seagen’s Tivdak a new antibody-drug conjugate for the treatment of cervical cancer.
The biologics market faces significant challenges, primarily related to the high costs associated with their development and production. Biologics are complicated compounds that necessitate specialized production procedures, and the development cost might be prohibitively expensive. Furthermore, increasing competition from biosimilars is also a key restraining factor for the market. In 2021, Europe approved seven new biosimilars, a slight decrease from the nine approved in 2020. It is anticipated that during the forecast years oncology, endocrine and blood related disorders are the key therapies areas in which biologic drugs will face patent expiry.
As of 2022, there were already 27 cell and gene therapy drugs approved in the U. S., with five of them receiving approval that year. Sarepta’s gene therapy SRP-9001, which is currently in phase 3 trials for the treatment of duchenne muscular dystrophy has a PDUFA date set for May 29, 2023. Other potential gene therapy candidates in the pipeline include Krystal Biotech’s Beremagene geperpavec (B-VEC) for dystrophic epidermolysis bullosa; UniQure’s AMT-130 for Huntington disease; Intellia’s NTLA-2001 and NTLA-2002 for transthyretin (ATTR) amyloidosis; Nanoscope’s MCO-010 and Pfizer’s Fidanacogene elaparvovec for hemophilia B. The approval and subsequent commercialization of these gene therapy candidates are expected to drive growth in the biologics market.
Monoclonal antibodies account for the largest number of biologics approved. While the approval of traditional monoclonal antibodies has slowed down, next-generation antibodies such a bispecific-monoclonal antibodies, antibody fragments, radio-immunotherapies, nanobodies, and antibody-drug conjugates is driving the growth of this segment. For instance, in September 2021, the U. S. FDA approved Seagen’s Tivdak a new antibody-drug conjugate for the treatment of cervical cancer.
The biologics market faces significant challenges, primarily related to the high costs associated with their development and production. Biologics are complicated compounds that necessitate specialized production procedures, and the development cost might be prohibitively expensive. Furthermore, increasing competition from biosimilars is also a key restraining factor for the market. In 2021, Europe approved seven new biosimilars, a slight decrease from the nine approved in 2020. It is anticipated that during the forecast years oncology, endocrine and blood related disorders are the key therapies areas in which biologic drugs will face patent expiry.
Biologics Market Report Highlights
- Based on source, the mammalian expression systems segment is expected to grow at the fastest CAGR during the forecast period. The microbial expression system dominated the market in 2022
- Based on disease category, the oncology segment dominated the biologics market in 2022 with a share of 28.40%. Most of monoclonal antibodies and other biologic drugs have been approved for cancer indication
- The haemotological diseases segment is expected to expand at the fastest CAGR during the forecast period, owing to the approval of gene therapy candidates for hemophilia
- Based on product, the monoclonal antibodies segment dominated the market with a share of 66.42% in 2022
- North America was the largest revenue generating region in the biologics market in 2022. The availability of favorable reimbursement policies of high-cost biologics, presence of major players and high investment in R&D are some of the key factors for the regions dominance
Table of Contents
Chapter 1. Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Definitions
1.1.1.1 Disease
1.1.1.2 Product
1.1.1.3 Source
1.1.1.4 Manufacturing site
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List of Secondary Sources
1.11 List of Abbreviations
1.1.1 Segment Definitions
1.1.1.1 Disease
1.1.1.2 Product
1.1.1.3 Source
1.1.1.4 Manufacturing site
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List of Secondary Sources
1.11 List of Abbreviations
Chapter 2. Executive Summary
2.1 Market Outlook
2.2 Segment Insights
2.2 Segment Insights
Chapter 3. Biologics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.2. Penetration and Growth Prospect Mapping
3.3. User Perspective Analysis
3.4. Market Dynamics
3.4.1. Market Dynamics
3.4.1.1. Advancements in biomedical science
3.4.1.2. Rise in biologics contract manufacturing services
3.4.1.3. Several drugs going off patents
3.4.1.4. Commercial success of biologics
3.4.2. Market Restraint Analysis
3.4.2.1. Pharmacokinetics challenges associated with biologics
3.4.2.2. Rising control & cost for accessing biologics
3.4.2.3. Development of biosimilars
3.5. Biologics -Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.6. Industry Analysis - Porter’s
3.7. Biologics: Pipeline Analysis
3.1.1. Parent market outlook
3.2. Penetration and Growth Prospect Mapping
3.3. User Perspective Analysis
3.4. Market Dynamics
3.4.1. Market Dynamics
3.4.1.1. Advancements in biomedical science
3.4.1.2. Rise in biologics contract manufacturing services
3.4.1.3. Several drugs going off patents
3.4.1.4. Commercial success of biologics
3.4.2. Market Restraint Analysis
3.4.2.1. Pharmacokinetics challenges associated with biologics
3.4.2.2. Rising control & cost for accessing biologics
3.4.2.3. Development of biosimilars
3.5. Biologics -Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.6. Industry Analysis - Porter’s
3.7. Biologics: Pipeline Analysis
Chapter 4. Biologics Market: Segment Analysis, By Source, 2018 - 2030 (USD Billion)
4.1. Global Biologics Market: Source Movement Analysis
4.2. Microbial Source
4.2.1. Global microbial source market, 2018 - 2030 (USD Billion)
4.3. Mammalian Source
4.3.1. Global mammalian source market, 2018 - 2030 (USD Billion)
4.4. Others
4.4.1. Global other source market, 2018 - 2030 (USD Billion)
4.2. Microbial Source
4.2.1. Global microbial source market, 2018 - 2030 (USD Billion)
4.3. Mammalian Source
4.3.1. Global mammalian source market, 2018 - 2030 (USD Billion)
4.4. Others
4.4.1. Global other source market, 2018 - 2030 (USD Billion)
Chapter 5. Biologics Market: Segment Analysis, By Product, 2018 - 2030 (USD Billion)
5.1. Global Biologics Market: Product Movement Analysis
5.2. Monoclonal Antibodies
5.2.1. Global monoclonal antibodies market, 2018 - 2030 (USD Billion)
5.2.2. Monoclonal antibodies by application
5.2.2.1. Diagnostic monoclonal antibodies
5.2.2.1.1. Diagnostic MABs market, 2018 - 2030 (USD Billion)
5.2.2.1.2. Diagnostic MABs for biochemical analysis
5.2.2.1.3. Diagnostic MABs for imaging
5.2.2.2. Therapeutic MABs
5.2.2.2.1. Therapeutic MABs market, 2018 - 2030 (USD Billion)
5.2.2.2.2. Direct MABs
5.2.2.2.3. Targeting MABs
5.2.2.3. Protein purification MABs
5.2.2.3.1. Protein purification MABs market, 2018 - 2030 (USD Billion)
5.2.2.4. Other MABs
5.2.2.4.1. Other MABs market, 2018 - 2030 (USD Billion)
5.2.3. Monoclonal antibodies by type
5.2.3.1. Murine MABs
5.2.3.1.1. Murine MABs market, 2018 - 2030 (USD Billion)
5.2.3.2. Chimeric MABs
5.2.3.2.1. Chimeric MABs market, 2018 - 2030 (USD Billion)
5.2.3.3. Humanized MABs
5.2.3.3.1. Humanized MABs market, 2018 - 2030 (USD Billion)
5.2.3.4. Human MABs
5.2.3.4.1. Human MABs market, 2018 - 2030 (USD Billion)
5.2.3.5. Other MABs
5.2.3.5.1. Other MABs market, 2018 - 2030 (USD Billion)
5.3. Vaccines
5.3.1. Global vaccines market, 2018 - 2030 (USD Billion)
5.4. Recombinant Proteins
5.4.1. Global recombinant proteins market, 2018 - 2030 (USD Billion)
5.5. Antisense & RNAi Therapeutics
5.5.1. Global Antisense & RNAi Therapeutics market, 2018 - 2030 (USD Billion)
5.6. Others
5.6.1. Global other product market, 2018 - 2030 (USD Billion)
5.2. Monoclonal Antibodies
5.2.1. Global monoclonal antibodies market, 2018 - 2030 (USD Billion)
5.2.2. Monoclonal antibodies by application
5.2.2.1. Diagnostic monoclonal antibodies
5.2.2.1.1. Diagnostic MABs market, 2018 - 2030 (USD Billion)
5.2.2.1.2. Diagnostic MABs for biochemical analysis
5.2.2.1.3. Diagnostic MABs for imaging
5.2.2.2. Therapeutic MABs
5.2.2.2.1. Therapeutic MABs market, 2018 - 2030 (USD Billion)
5.2.2.2.2. Direct MABs
5.2.2.2.3. Targeting MABs
5.2.2.3. Protein purification MABs
5.2.2.3.1. Protein purification MABs market, 2018 - 2030 (USD Billion)
5.2.2.4. Other MABs
5.2.2.4.1. Other MABs market, 2018 - 2030 (USD Billion)
5.2.3. Monoclonal antibodies by type
5.2.3.1. Murine MABs
5.2.3.1.1. Murine MABs market, 2018 - 2030 (USD Billion)
5.2.3.2. Chimeric MABs
5.2.3.2.1. Chimeric MABs market, 2018 - 2030 (USD Billion)
5.2.3.3. Humanized MABs
5.2.3.3.1. Humanized MABs market, 2018 - 2030 (USD Billion)
5.2.3.4. Human MABs
5.2.3.4.1. Human MABs market, 2018 - 2030 (USD Billion)
5.2.3.5. Other MABs
5.2.3.5.1. Other MABs market, 2018 - 2030 (USD Billion)
5.3. Vaccines
5.3.1. Global vaccines market, 2018 - 2030 (USD Billion)
5.4. Recombinant Proteins
5.4.1. Global recombinant proteins market, 2018 - 2030 (USD Billion)
5.5. Antisense & RNAi Therapeutics
5.5.1. Global Antisense & RNAi Therapeutics market, 2018 - 2030 (USD Billion)
5.6. Others
5.6.1. Global other product market, 2018 - 2030 (USD Billion)
Chapter 6. Biologics Market: Segment Analysis, By Manufacturing, 2018 - 2030 (USD Billion)
6.1. Global Biologics Market: Manufacturing Movement Analysis
6.2. Outsourced
6.2.1. Global outsourced market, 2018 - 2030 (USD Billion)
6.3. In-house
6.3.1. Global in-house market, 2018 - 2030 (USD Billion)
6.2. Outsourced
6.2.1. Global outsourced market, 2018 - 2030 (USD Billion)
6.3. In-house
6.3.1. Global in-house market, 2018 - 2030 (USD Billion)
Chapter 7. Biologics Market: Segment Analysis, By Disease, 2018 - 2030 (USD Billion)
7.1. Global Biologics Market: Disease Category Movement Analysis
7.2. Oncology
7.2.1. Global oncology market, 2018 - 2030 (USD Billion)
7.2.2. MABs market for oncology
7.2.2.1. Global MABs market for oncology, 2018 - 2030 (USD Billion)
7.2.3. Vaccines market for oncology
7.2.3.1. Global vaccines market for oncology, 2018 - 2030 (USD Billion)
7.2.4. Recombinant proteins market for oncology
7.2.4.1. Global recombinant proteins market for oncology, 2018 - 2030 (USD Billion)
7.2.5. Antisense & RNAi Therapeutics market for oncology
7.2.5.1. Global Antisense & RNAi Therapeutics market for oncology, 2018 - 2030 (USD Billion)
7.2.6. Other products market for oncology
7.2.6.1. Global products market for oncology, 2018 - 2030 (USD Billion)
7.3. Infectious Disease
7.3.1. Global infectious disease market, 2018 - 2030 (USD Billion)
7.3.2. Vaccines market for infectious disease
7.3.2.1. Global vaccines market for infectious disease, 2018 - 2030 (USD Billion)
7.3.3. MABs market for infectious disease
7.3.3.1. Global MABs market for infectious disease, 2018 - 2030 (USD Billion)
7.3.4. Antisense & RNAi Therapeutics market for infectious disease
7.3.4.1. Global Antisense & RNAi Therapeutics market for infectious disease, 2018 - 2030 (USD Billion)
7.3.5. Recombinant proteins market for infectious disease
7.3.5.1. Global recombinant proteins market for infectious disease, 2018 - 2030 (USD Billion)
7.3.6. Other products market for infectious disease
7.3.6.1. Global products market for infectious disease, 2018 - 2030 (USD Billion)
7.4. Immunological Disorders
7.4.1. Global immunological disorders market, 2018 - 2030 (USD Billion)
7.5. Cardiovascular disorders
7.5.1. Global cardiovascular disorders market, 2018 - 2030 (USD Billion)
7.6. Hematologic Disorders
7.6.1. Global hematologic disorders market, 2018 - 2030 (USD Billion)
7.7. Others
7.7.1. Global other indications market, 2018 - 2030 (USD Billion)
7.2. Oncology
7.2.1. Global oncology market, 2018 - 2030 (USD Billion)
7.2.2. MABs market for oncology
7.2.2.1. Global MABs market for oncology, 2018 - 2030 (USD Billion)
7.2.3. Vaccines market for oncology
7.2.3.1. Global vaccines market for oncology, 2018 - 2030 (USD Billion)
7.2.4. Recombinant proteins market for oncology
7.2.4.1. Global recombinant proteins market for oncology, 2018 - 2030 (USD Billion)
7.2.5. Antisense & RNAi Therapeutics market for oncology
7.2.5.1. Global Antisense & RNAi Therapeutics market for oncology, 2018 - 2030 (USD Billion)
7.2.6. Other products market for oncology
7.2.6.1. Global products market for oncology, 2018 - 2030 (USD Billion)
7.3. Infectious Disease
7.3.1. Global infectious disease market, 2018 - 2030 (USD Billion)
7.3.2. Vaccines market for infectious disease
7.3.2.1. Global vaccines market for infectious disease, 2018 - 2030 (USD Billion)
7.3.3. MABs market for infectious disease
7.3.3.1. Global MABs market for infectious disease, 2018 - 2030 (USD Billion)
7.3.4. Antisense & RNAi Therapeutics market for infectious disease
7.3.4.1. Global Antisense & RNAi Therapeutics market for infectious disease, 2018 - 2030 (USD Billion)
7.3.5. Recombinant proteins market for infectious disease
7.3.5.1. Global recombinant proteins market for infectious disease, 2018 - 2030 (USD Billion)
7.3.6. Other products market for infectious disease
7.3.6.1. Global products market for infectious disease, 2018 - 2030 (USD Billion)
7.4. Immunological Disorders
7.4.1. Global immunological disorders market, 2018 - 2030 (USD Billion)
7.5. Cardiovascular disorders
7.5.1. Global cardiovascular disorders market, 2018 - 2030 (USD Billion)
7.6. Hematologic Disorders
7.6.1. Global hematologic disorders market, 2018 - 2030 (USD Billion)
7.7. Others
7.7.1. Global other indications market, 2018 - 2030 (USD Billion)
Chapter 8. Biologics Market: Segment Analysis, By Region, 2018 - 2030 (USD Billion)
8.1 Biologics Market: Regional Outlook
8.2 North America
8.2.1 North America Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.2.2 U.S.
8.2.2.1 Key Country Dynamics
8.2.2.2 U.S. Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.2.2.3 Target Disease Prevalence
8.2.2.4 Competitive Scenario
8.2.2.5 Regulatory Framework
8.2.2.6 Reimbursement Scenario
8.2.3 Canada
8.2.3.1 Key Country Dynamics
8.2.3.2 Canada Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.2.3.3 Target Disease Prevalence
8.2.3.4 Competitive Scenario
8.2.3.5 Regulatory Framework
8.2.3.6 Reimbursement Scenario
8.3 Europe
8.3.1 Europe Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.3.2 UK
8.3.2.1 Key Country Dynamics
8.3.2.2 UK Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.3.2.3 Target Disease Prevalence
8.3.2.4 Competitive Scenario
8.3.2.5 Regulatory Framework
8.3.2.6 Reimbursement Scenario
8.3.3 Germany
8.3.3.1 Key Country Dynamics
8.3.3.2 Germany Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.3.3.3 Target Disease Prevalence
8.3.3.4 Competitive Scenario
8.3.3.5 Regulatory Framework
8.3.3.6 Reimbursement Scenario
8.3.4 France
8.3.4.1 Key Country Dynamics
8.3.4.2 France Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.3.4.3 Target Disease Prevalence
8.3.4.4 Competitive Scenario
8.3.4.5 Regulatory Framework
8.3.4.6 Reimbursement Scenario
8.3.5 Italy
8.3.5.1 Key Country Dynamics
8.3.5.2 Italy Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.3.5.3 Target Disease Prevalence
8.3.5.4 Competitive Scenario
8.3.5.5 Regulatory Framework
8.3.5.6 Reimbursement Scenario
8.3.6 Spain
8.3.6.1 Key Country Dynamics
8.3.6.2 Spain Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.3.6.3 Target Disease Prevalence
8.3.6.4 Competitive Scenario
8.3.6.5 Regulatory Framework
8.3.6.6 Reimbursement Scenario
8.3.7 Denmark
8.3.7.1 Key Country Dynamics
8.3.7.2 Denmark Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.3.7.3 Target Disease Prevalence
8.3.7.4 Competitive Scenario
8.3.7.5 Regulatory Framework
8.3.7.6 Reimbursement Scenario
8.3.8 Sweden
8.3.8.1 Key Country Dynamics
8.3.8.2 Sweden Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.3.8.3 Target Disease Prevalence
8.3.8.4 Competitive Scenario
8.3.8.5 Regulatory Framework
8.3.8.6 Reimbursement Scenario
8.3.9 Norway
8.3.9.1 Key Country Dynamics
8.3.9.2 Norway Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.3.9.3 Target Disease Prevalence
8.3.9.4 Competitive Scenario
8.3.9.5 Regulatory Framework
8.3.9.6 Reimbursement Scenario
8.4 Asia Pacific
8.4.1 Asia Pacific Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.4.2 Japan
8.4.2.1 Key Country Dynamics
8.4.2.2 Japan Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.4.2.3 Target Disease Prevalence
8.4.2.4 Competitive Scenario
8.4.2.5 Regulatory Framework
8.4.2.6 Reimbursement Scenario
8.4.3 China
8.4.3.1 Key Country Dynamics
8.4.3.2 China Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.4.3.3 Target Disease Prevalence
8.4.3.4 Competitive Scenario
8.4.3.5 Regulatory Framework
8.4.3.6 Reimbursement Scenario
8.4.4 India
8.4.4.1 Key Country Dynamics
8.4.4.2 India Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.4.4.3 Target Disease Prevalence
8.4.4.4 Competitive Scenario
8.4.4.5 Regulatory Framework
8.4.4.6 Reimbursement Scenario
8.4.5 Australia
8.4.5.1 Key Country Dynamics
8.4.5.2 Australia Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.4.5.3 Target Disease Prevalence
8.4.5.4 Competitive Scenario
8.4.5.5 Regulatory Framework
8.4.5.6 Reimbursement Scenario
8.4.6 South Korea
8.4.6.1 Key Country Dynamics
8.4.6.2 South Korea Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.4.6.3 Target Disease Prevalence
8.4.6.4 Competitive Scenario
8.4.6.5 Regulatory Framework
8.4.6.6 Reimbursement Scenario
8.4.7 Thailand
8.4.7.1 Key Country Dynamics
8.4.7.2 Thailand Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.4.7.3 Target Disease Prevalence
8.4.7.4 Competitive Scenario
8.4.7.5 Regulatory Framework
8.4.7.6 Reimbursement Scenario
8.5 Latin America
8.5.1 Latin America Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.5.2 Brazil
8.5.2.1 Key Country Dynamics
8.5.2.2 Brazil Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.5.2.3 Target Disease Prevalence
8.5.2.4 Competitive Scenario
8.5.2.5 Regulatory Framework
8.5.2.6 Reimbursement Scenario
8.5.3 Mexico
8.5.3.1 Key Country Dynamics
8.5.3.2 Mexico Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.5.3.3 Target Disease Prevalence
8.5.3.4 Competitive Scenario
8.5.3.5 Regulatory Framework
8.5.3.6 Reimbursement Scenario
8.5.4 Argentina
8.5.4.1 Key Country Dynamics
8.5.4.2 Argentina Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.5.4.3 Target Disease Prevalence
8.5.4.4 Competitive Scenario
8.5.4.5 Regulatory Framework
8.5.4.6 Reimbursement Scenario
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.6.1.1 Target Disease Prevalence
8.6.1.2 Competitive Scenario
8.6.1.3 Regulatory Framework
8.6.1.4 Reimbursement Scenario
8.6.2 South Africa
8.6.2.1 Key Country Dynamics
8.6.2.2 South Africa Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.6.2.3 Target Disease Prevalence
8.6.2.4 Competitive Scenario
8.6.2.5 Regulatory Framework
8.6.2.6 Reimbursement Scenario
8.6.3 Saudi Arabia
8.6.3.1 Key Country Dynamics
8.6.3.2 Saudi Arabia Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.6.3.3 Target Disease Prevalence
8.6.3.4 Competitive Scenario
8.6.3.5 Regulatory Framework
8.6.3.6 Reimbursement Scenario
8.6.4 UAE
8.6.4.1 Key Country Dynamics
8.6.4.2 UAE Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.6.4.3 Target Disease Prevalence
8.6.4.4 Competitive Scenario
8.6.4.5 Regulatory Framework
8.6.4.6 Reimbursement Scenario
8.6.5 KUWAIT
8.6.5.1 Key Country Dynamics
8.6.5.2 Kuwait Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.6.5.3 Target Disease Prevalence
8.6.5.4 Competitive Scenario
8.6.5.5 Regulatory Framework
8.6.5.6 Reimbursement Scenario
8.2 North America
8.2.1 North America Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.2.2 U.S.
8.2.2.1 Key Country Dynamics
8.2.2.2 U.S. Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.2.2.3 Target Disease Prevalence
8.2.2.4 Competitive Scenario
8.2.2.5 Regulatory Framework
8.2.2.6 Reimbursement Scenario
8.2.3 Canada
8.2.3.1 Key Country Dynamics
8.2.3.2 Canada Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.2.3.3 Target Disease Prevalence
8.2.3.4 Competitive Scenario
8.2.3.5 Regulatory Framework
8.2.3.6 Reimbursement Scenario
8.3 Europe
8.3.1 Europe Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.3.2 UK
8.3.2.1 Key Country Dynamics
8.3.2.2 UK Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.3.2.3 Target Disease Prevalence
8.3.2.4 Competitive Scenario
8.3.2.5 Regulatory Framework
8.3.2.6 Reimbursement Scenario
8.3.3 Germany
8.3.3.1 Key Country Dynamics
8.3.3.2 Germany Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.3.3.3 Target Disease Prevalence
8.3.3.4 Competitive Scenario
8.3.3.5 Regulatory Framework
8.3.3.6 Reimbursement Scenario
8.3.4 France
8.3.4.1 Key Country Dynamics
8.3.4.2 France Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.3.4.3 Target Disease Prevalence
8.3.4.4 Competitive Scenario
8.3.4.5 Regulatory Framework
8.3.4.6 Reimbursement Scenario
8.3.5 Italy
8.3.5.1 Key Country Dynamics
8.3.5.2 Italy Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.3.5.3 Target Disease Prevalence
8.3.5.4 Competitive Scenario
8.3.5.5 Regulatory Framework
8.3.5.6 Reimbursement Scenario
8.3.6 Spain
8.3.6.1 Key Country Dynamics
8.3.6.2 Spain Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.3.6.3 Target Disease Prevalence
8.3.6.4 Competitive Scenario
8.3.6.5 Regulatory Framework
8.3.6.6 Reimbursement Scenario
8.3.7 Denmark
8.3.7.1 Key Country Dynamics
8.3.7.2 Denmark Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.3.7.3 Target Disease Prevalence
8.3.7.4 Competitive Scenario
8.3.7.5 Regulatory Framework
8.3.7.6 Reimbursement Scenario
8.3.8 Sweden
8.3.8.1 Key Country Dynamics
8.3.8.2 Sweden Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.3.8.3 Target Disease Prevalence
8.3.8.4 Competitive Scenario
8.3.8.5 Regulatory Framework
8.3.8.6 Reimbursement Scenario
8.3.9 Norway
8.3.9.1 Key Country Dynamics
8.3.9.2 Norway Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.3.9.3 Target Disease Prevalence
8.3.9.4 Competitive Scenario
8.3.9.5 Regulatory Framework
8.3.9.6 Reimbursement Scenario
8.4 Asia Pacific
8.4.1 Asia Pacific Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.4.2 Japan
8.4.2.1 Key Country Dynamics
8.4.2.2 Japan Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.4.2.3 Target Disease Prevalence
8.4.2.4 Competitive Scenario
8.4.2.5 Regulatory Framework
8.4.2.6 Reimbursement Scenario
8.4.3 China
8.4.3.1 Key Country Dynamics
8.4.3.2 China Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.4.3.3 Target Disease Prevalence
8.4.3.4 Competitive Scenario
8.4.3.5 Regulatory Framework
8.4.3.6 Reimbursement Scenario
8.4.4 India
8.4.4.1 Key Country Dynamics
8.4.4.2 India Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.4.4.3 Target Disease Prevalence
8.4.4.4 Competitive Scenario
8.4.4.5 Regulatory Framework
8.4.4.6 Reimbursement Scenario
8.4.5 Australia
8.4.5.1 Key Country Dynamics
8.4.5.2 Australia Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.4.5.3 Target Disease Prevalence
8.4.5.4 Competitive Scenario
8.4.5.5 Regulatory Framework
8.4.5.6 Reimbursement Scenario
8.4.6 South Korea
8.4.6.1 Key Country Dynamics
8.4.6.2 South Korea Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.4.6.3 Target Disease Prevalence
8.4.6.4 Competitive Scenario
8.4.6.5 Regulatory Framework
8.4.6.6 Reimbursement Scenario
8.4.7 Thailand
8.4.7.1 Key Country Dynamics
8.4.7.2 Thailand Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.4.7.3 Target Disease Prevalence
8.4.7.4 Competitive Scenario
8.4.7.5 Regulatory Framework
8.4.7.6 Reimbursement Scenario
8.5 Latin America
8.5.1 Latin America Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.5.2 Brazil
8.5.2.1 Key Country Dynamics
8.5.2.2 Brazil Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.5.2.3 Target Disease Prevalence
8.5.2.4 Competitive Scenario
8.5.2.5 Regulatory Framework
8.5.2.6 Reimbursement Scenario
8.5.3 Mexico
8.5.3.1 Key Country Dynamics
8.5.3.2 Mexico Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.5.3.3 Target Disease Prevalence
8.5.3.4 Competitive Scenario
8.5.3.5 Regulatory Framework
8.5.3.6 Reimbursement Scenario
8.5.4 Argentina
8.5.4.1 Key Country Dynamics
8.5.4.2 Argentina Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.5.4.3 Target Disease Prevalence
8.5.4.4 Competitive Scenario
8.5.4.5 Regulatory Framework
8.5.4.6 Reimbursement Scenario
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.6.1.1 Target Disease Prevalence
8.6.1.2 Competitive Scenario
8.6.1.3 Regulatory Framework
8.6.1.4 Reimbursement Scenario
8.6.2 South Africa
8.6.2.1 Key Country Dynamics
8.6.2.2 South Africa Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.6.2.3 Target Disease Prevalence
8.6.2.4 Competitive Scenario
8.6.2.5 Regulatory Framework
8.6.2.6 Reimbursement Scenario
8.6.3 Saudi Arabia
8.6.3.1 Key Country Dynamics
8.6.3.2 Saudi Arabia Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.6.3.3 Target Disease Prevalence
8.6.3.4 Competitive Scenario
8.6.3.5 Regulatory Framework
8.6.3.6 Reimbursement Scenario
8.6.4 UAE
8.6.4.1 Key Country Dynamics
8.6.4.2 UAE Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.6.4.3 Target Disease Prevalence
8.6.4.4 Competitive Scenario
8.6.4.5 Regulatory Framework
8.6.4.6 Reimbursement Scenario
8.6.5 KUWAIT
8.6.5.1 Key Country Dynamics
8.6.5.2 Kuwait Biologics Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
8.6.5.3 Target Disease Prevalence
8.6.5.4 Competitive Scenario
8.6.5.5 Regulatory Framework
8.6.5.6 Reimbursement Scenario
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.2.1. New Product Launch
9.2.2. Partnerships
9.2.3. Acquisition
9.2.4. Collaboration
9.2.5. Funding
9.3. Company Market Share Analysis, 2022
9.4. Company Profiles
9.4.1. Samsung BioLogics
9.4.1.1. Company Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Amgen
9.4.2.1. Company Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. Novo Nordisk A/S
9.4.3.1. Company Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. AbbVie Inc.
9.4.4.1. Company Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Sanofi
9.4.5.1. Company Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Johnson & Johnson Services, Inc
9.4.6.1. Company Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Celltrion
9.4.7.1. Company Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Bristol-Myers Squibb Company
9.4.8.1. Company Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Eli Lilly and Company
9.4.9.1. Company Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
9.2. Strategy Mapping
9.2.1. New Product Launch
9.2.2. Partnerships
9.2.3. Acquisition
9.2.4. Collaboration
9.2.5. Funding
9.3. Company Market Share Analysis, 2022
9.4. Company Profiles
9.4.1. Samsung BioLogics
9.4.1.1. Company Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Amgen
9.4.2.1. Company Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. Novo Nordisk A/S
9.4.3.1. Company Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. AbbVie Inc.
9.4.4.1. Company Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Sanofi
9.4.5.1. Company Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Johnson & Johnson Services, Inc
9.4.6.1. Company Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Celltrion
9.4.7.1. Company Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Bristol-Myers Squibb Company
9.4.8.1. Company Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Eli Lilly and Company
9.4.9.1. Company Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
TABLE 2 List of Abbreviations
TABLE 3 Global biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 4 Global biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 5 Global monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 6 Global diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 7 Global therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 8 Global monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 9 Global biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 10 Global biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 11 Global oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 12 Global infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 13 North America biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 14 North America biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 15 North America monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 16 North America diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 17 North America therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 18 North America monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 19 North America biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 20 North America biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 21 North America oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 22 North America infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 23 U.S. biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 24 U.S. biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 25 U.S. monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 26 U.S. diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 27 U.S. therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 28 U.S. monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 29 U.S. biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 30 U.S. biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 31 U.S. oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 32 U.S. infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 33 Canada biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 34 Canada biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 35 Canada monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 36 Canada diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 37 Canada therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 38 Canada monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 39 Canada biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 40 Canada biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 41 Canada oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 42 Canada infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 43 Europe biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 44 Europe biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 45 Europe monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 46 Europe diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 47 Europe therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 48 Europe monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 49 Europe biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 50 Europe biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 51 Europe oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 52 Europe infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 53 Germany biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 54 Germany biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 55 Germany monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 56 Germany diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 57 Germany therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 58 Germany monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 59 Germany biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 60 Germany biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 61 Germany oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 62 Germany infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 63 UK biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 64 UK biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 65 UK monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 66 UK diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 67 UK therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 68 UK monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 69 UK biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 70 UK biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 71 UK oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 72 UK infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 73 France biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 74 France biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 75 France monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 76 France diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 77 France therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 78 France monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 79 France biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 80 France biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 81 France oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 82 France infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 83 Italy biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 84 Italy biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 85 Italy monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 86 Italy diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 87 Italy therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 88 Italy monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 89 Italy biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 90 Italy biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 91 Italy oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 92 Italy infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 93 Spain biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 94 Spain biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 95 Spain monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 96 Spain diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 97 Spain therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 98 Spain monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 99 Spain biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 100 Spain biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 101 Spain oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 102 Spain infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 103 Denmark biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 104 Denmark biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 105 Denmark monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 106 Denmark diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 107 Denmark therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 108 Denmark monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 109 Denmark biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 110 Denmark biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 111 Denmark oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 112 Denmark infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 113 Sweden biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 114 Sweden biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 115 Sweden monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 116 Sweden diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 117 Sweden therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 118 Sweden monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 119 Sweden biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 120 Sweden biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 121 Sweden oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 122 Sweden infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 123 Norway biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 124 Norway biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 125 Norway monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 126 Norway diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 127 Norway therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 128 Norway monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 129 Norway biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 130 Norway biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 131 Norway oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 132 Norway infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 133 Asia Pacific biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 134 Asia Pacific biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 135 Asia Pacific monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 136 Asia Pacific diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 137 Asia Pacific therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 138 Asia Pacific monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 139 Asia Pacific biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 140 Asia Pacific biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 141 Asia Pacific oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 142 Asia Pacific infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 143 Japan biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 144 Japan biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 145 Japan monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 146 Japan diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 147 Japan therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 148 Japan monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 149 Japan biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 150 Japan biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 151 Japan oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 152 Japan infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 153 China biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 154 China biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 155 China monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 156 China diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 157 China therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 158 China monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 159 China biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 160 China biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 161 China oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 162 China infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 163 India biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 164 India biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 165 India monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 166 India diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 167 India therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 168 India monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 169 India biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 170 India biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 171 India oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 172 India infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 173 Australia biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 174 Australia biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 175 Australia monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 176 Australia diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 177 Australia therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 178 Australia monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 179 Australia biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 180 Australia biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 181 Australia oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 182 Australia infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 183 South Korea biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 184 South Korea biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 185 South Korea monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 186 South Korea diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 187 South Korea therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 188 South Korea monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 189 South Korea biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 190 South Korea biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 191 South Korea oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 192 South Korea infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 193 Thailand biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 194 Thailand biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 195 Thailand monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 196 Thailand diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 197 Thailand therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 198 Thailand monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 199 Thailand biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 200 Thailand biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 201 Thailand oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 202 Thailand infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 203 Latin America biologics market estimates & forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 204 Latin America biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 205 Latin America monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 206 Latin America diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 207 Latin America therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 208 Latin America monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 209 Latin America biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 210 Latin America biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 211 Latin America oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 212 Latin America infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 213 Brazil biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 214 Brazil biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 215 Brazil monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 216 Brazil diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 217 Brazil therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 218 Brazil monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 219 Brazil biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 220 Brazil biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 221 Brazil oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 222 Brazil infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 223 Mexico biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 224 Mexico biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 225 Mexico monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 226 Mexico diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 227 Mexico therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 228 Mexico monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 229 Mexico biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 230 Mexico biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 231 Mexico oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 232 Mexico infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 233 Argentina biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 234 Argentina biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 235 Argentina monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 236 Argentina diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 237 Argentina therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 238 Argentina monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 239 Argentina biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 240 Argentina biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 241 Argentina oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 242 Argentina infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 243 MEA biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 244 MEA biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 245 MEA monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 246 MEA diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 247 MEA therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 248 MEA monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 249 MEA biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 250 MEA biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 251 MEA oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 252 MEA infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 253 South Africa biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 254 South Africa biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 255 South Africa monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 256 South Africa diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 257 South Africa therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 258 South Africa monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 259 South Africa biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 260 South Africa biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 261 South Africa oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 262 South Africa infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 263 Saudi Arabia biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 264 Saudi Arabia biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 265 Saudi Arabia monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 266 Saudi Arabia diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 267 Saudi Arabia therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 268 Saudi Arabia monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 269 Saudi Arabia biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 270 Saudi Arabia biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 271 Saudi Arabia oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 272 Saudi Arabia infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 273 UAE biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 274 UAE biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 275 UAE monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 276 UAE diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 277 UAE therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 278 UAE monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 279 UAE biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 280 UAE biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 281 UAE oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 282 UAE infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 283 Kuwait biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 284 Kuwait biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 285 Kuwait monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 286 Kuwait diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 287 Kuwait therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 288 Kuwait monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 289 Kuwait biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 290 Kuwait biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 291 Kuwait oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 292 Kuwait infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 293 Company Overview
TABLE 294 Financial Performance
TABLE 295 Product Benchmarking
TABLE 296 Strategic Initiatives
TABLE 2 List of Abbreviations
TABLE 3 Global biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 4 Global biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 5 Global monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 6 Global diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 7 Global therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 8 Global monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 9 Global biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 10 Global biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 11 Global oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 12 Global infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 13 North America biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 14 North America biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 15 North America monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 16 North America diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 17 North America therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 18 North America monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 19 North America biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 20 North America biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 21 North America oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 22 North America infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 23 U.S. biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 24 U.S. biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 25 U.S. monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 26 U.S. diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 27 U.S. therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 28 U.S. monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 29 U.S. biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 30 U.S. biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 31 U.S. oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 32 U.S. infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 33 Canada biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 34 Canada biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 35 Canada monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 36 Canada diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 37 Canada therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 38 Canada monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 39 Canada biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 40 Canada biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 41 Canada oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 42 Canada infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 43 Europe biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 44 Europe biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 45 Europe monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 46 Europe diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 47 Europe therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 48 Europe monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 49 Europe biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 50 Europe biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 51 Europe oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 52 Europe infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 53 Germany biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 54 Germany biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 55 Germany monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 56 Germany diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 57 Germany therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 58 Germany monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 59 Germany biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 60 Germany biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 61 Germany oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 62 Germany infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 63 UK biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 64 UK biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 65 UK monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 66 UK diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 67 UK therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 68 UK monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 69 UK biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 70 UK biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 71 UK oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 72 UK infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 73 France biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 74 France biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 75 France monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 76 France diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 77 France therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 78 France monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 79 France biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 80 France biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 81 France oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 82 France infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 83 Italy biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 84 Italy biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 85 Italy monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 86 Italy diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 87 Italy therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 88 Italy monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 89 Italy biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 90 Italy biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 91 Italy oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 92 Italy infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 93 Spain biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 94 Spain biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 95 Spain monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 96 Spain diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 97 Spain therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 98 Spain monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 99 Spain biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 100 Spain biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 101 Spain oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 102 Spain infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 103 Denmark biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 104 Denmark biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 105 Denmark monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 106 Denmark diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 107 Denmark therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 108 Denmark monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 109 Denmark biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 110 Denmark biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 111 Denmark oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 112 Denmark infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 113 Sweden biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 114 Sweden biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 115 Sweden monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 116 Sweden diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 117 Sweden therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 118 Sweden monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 119 Sweden biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 120 Sweden biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 121 Sweden oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 122 Sweden infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 123 Norway biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 124 Norway biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 125 Norway monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 126 Norway diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 127 Norway therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 128 Norway monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 129 Norway biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 130 Norway biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 131 Norway oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 132 Norway infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 133 Asia Pacific biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 134 Asia Pacific biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 135 Asia Pacific monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 136 Asia Pacific diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 137 Asia Pacific therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 138 Asia Pacific monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 139 Asia Pacific biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 140 Asia Pacific biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 141 Asia Pacific oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 142 Asia Pacific infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 143 Japan biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 144 Japan biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 145 Japan monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 146 Japan diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 147 Japan therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 148 Japan monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 149 Japan biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 150 Japan biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 151 Japan oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 152 Japan infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 153 China biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 154 China biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 155 China monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 156 China diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 157 China therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 158 China monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 159 China biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 160 China biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 161 China oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 162 China infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 163 India biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 164 India biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 165 India monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 166 India diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 167 India therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 168 India monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 169 India biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 170 India biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 171 India oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 172 India infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 173 Australia biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 174 Australia biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 175 Australia monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 176 Australia diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 177 Australia therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 178 Australia monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 179 Australia biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 180 Australia biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 181 Australia oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 182 Australia infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 183 South Korea biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 184 South Korea biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 185 South Korea monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 186 South Korea diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 187 South Korea therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 188 South Korea monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 189 South Korea biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 190 South Korea biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 191 South Korea oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 192 South Korea infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 193 Thailand biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 194 Thailand biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 195 Thailand monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 196 Thailand diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 197 Thailand therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 198 Thailand monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 199 Thailand biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 200 Thailand biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 201 Thailand oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 202 Thailand infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 203 Latin America biologics market estimates & forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 204 Latin America biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 205 Latin America monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 206 Latin America diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 207 Latin America therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 208 Latin America monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 209 Latin America biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 210 Latin America biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 211 Latin America oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 212 Latin America infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 213 Brazil biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 214 Brazil biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 215 Brazil monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 216 Brazil diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 217 Brazil therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 218 Brazil monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 219 Brazil biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 220 Brazil biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 221 Brazil oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 222 Brazil infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 223 Mexico biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 224 Mexico biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 225 Mexico monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 226 Mexico diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 227 Mexico therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 228 Mexico monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 229 Mexico biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 230 Mexico biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 231 Mexico oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 232 Mexico infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 233 Argentina biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 234 Argentina biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 235 Argentina monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 236 Argentina diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 237 Argentina therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 238 Argentina monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 239 Argentina biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 240 Argentina biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 241 Argentina oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 242 Argentina infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 243 MEA biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 244 MEA biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 245 MEA monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 246 MEA diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 247 MEA therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 248 MEA monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 249 MEA biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 250 MEA biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 251 MEA oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 252 MEA infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 253 South Africa biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 254 South Africa biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 255 South Africa monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 256 South Africa diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 257 South Africa therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 258 South Africa monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 259 South Africa biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 260 South Africa biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 261 South Africa oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 262 South Africa infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 263 Saudi Arabia biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 264 Saudi Arabia biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 265 Saudi Arabia monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 266 Saudi Arabia diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 267 Saudi Arabia therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 268 Saudi Arabia monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 269 Saudi Arabia biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 270 Saudi Arabia biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 271 Saudi Arabia oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 272 Saudi Arabia infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 273 UAE biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 274 UAE biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 275 UAE monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 276 UAE diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 277 UAE therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 278 UAE monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 279 UAE biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 280 UAE biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 281 UAE oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 282 UAE infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 283 Kuwait biologics market estimates& forecasts, by source, 2018 - 2030 (USD Billion)
TABLE 284 Kuwait biologics market estimates& forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 285 Kuwait monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 286 Kuwait diagnostic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 287 Kuwait therapeutic monoclonal antibodies market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
TABLE 288 Kuwait monoclonal antibodies market estimates & forecasts, by type, 2018 - 2030 (USD Billion)
TABLE 289 Kuwait biologics market estimates & forecasts, by manufacturing, 2018 - 2030 (USD Billion)
TABLE 290 Kuwait biologics market estimates & forecasts, by therapeutic area, 2018 - 2030 (USD Billion)
TABLE 291 Kuwait oncology biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 292 Kuwait infectious diseases biologics market estimates & forecasts, by product, 2018 - 2030 (USD Billion)
TABLE 293 Company Overview
TABLE 294 Financial Performance
TABLE 295 Product Benchmarking
TABLE 296 Strategic Initiatives
List of Figures
Fig. 1 Biologics Market Segmentation
FIG. 2 Market research process
FIG. 3 Information Procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain based sizing & forecasting
FIG. 7 QFD modelling for market share assessment
FIG. 8 Market summary
FIG. 9 Market trends & outlook
FIG. 10 Market segmentation & scope
FIG. 11 Market driver relevance analysis (Current & future impact)
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 Penetration & growth prospect mapping for Product, 2016
FIG. 14 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 15 Porter’s Five Forces Analysis
FIG. 16 Global biologics market: Source outlook key takeaways
FIG. 17 Global biologics market: Source movement analysis
FIG. 18 Global microbial source market, 2018 - 2030 (USD Billion)
FIG. 19 Global mammalian source market, 2018 - 2030 (USD Billion)
FIG. 20 Global other source market, 2018 - 2030 (USD Billion)
FIG. 21 Global biologics market: Product outlook key takeaways
FIG. 22 Global biologics market: Product movement analysis
FIG. 23 Global monoclonal antibodies market, 2018 - 2030 (USD Billion)
FIG. 24 Global diagnostic MABs market, 2018 - 2030 (USD Billion)
FIG. 25 Global diagnostic MABs for biochemical analysis market, 2018 - 2030 (USD Billion)
FIG. 26 Global diagnostic MABs for imaging market, 2018 - 2030 (USD Billion)
FIG. 27 Global therapeutic MABs market, 2018 - 2030 (USD Billion)
FIG. 28 Global direct MABs market, 2018 - 2030 (USD Billion)
FIG. 29 Global targeting MABs market, 2018 - 2030 (USD Billion)
FIG. 30 Global protein purification MABs market, 2018 - 2030 (USD Billion)
FIG. 31 Global other MABs market, 2018 - 2030 (USD Billion)
FIG. 32 Global murine MABs market, 2018 - 2030 (USD Billion)
FIG. 33 Global chimeric MABs market, 2018 - 2030 (USD Billion)
FIG. 34 Global humanized MABs market, 2018 - 2030 (USD Billion)
FIG. 35 Global human MABs market, 2018 - 2030 (USD Billion)
FIG. 36 Global other MABs market, 2018 - 2030 (USD Billion)
FIG. 37 Global vaccines market, 2018 - 2030 (USD Billion)
FIG. 38 Global recombinant proteins market, 2018 - 2030 (USD Billion)
FIG. 39 Global Antisense & RNAi Therapeutics market, 2018 - 2030 (USD Billion)
FIG. 40 Global other product market, 2018 - 2030 (USD Billion)
FIG. 41 Global biologics market: Manufacturing outlook key takeaways
FIG. 42 Global biologics market: Manufacturing movement analysis
FIG. 43 Global outsourced market, 2018 - 2030 (USD Billion)
FIG. 44 Global in-house market, 2018 - 2030 (USD Billion)
FIG. 45 Global biologics market: Disease category outlook key takeaways
FIG. 46 Global biologics market: Disease category movement analysis
FIG. 47 Global oncology market, 2018 - 2030 (USD Billion)
FIG. 48 Global infectious disease market, 2018 - 2030 (USD Billion)
FIG. 49 Global immunological disorders market, 2018 - 2030 (USD Billion)
FIG. 50 Global cardiovascular disorders market, 2018 - 2030 (USD Billion)
FIG. 51 Global hematologic disorders market, 2018 - 2030 (USD Billion)
FIG. 52 Global other indications market, 2018 - 2030 (USD Billion)
FIG. 53 Regional market place: Key takeaway
FIG. 54 North America biologics market, 2018 - 2030 (USD Billion)
FIG. 55 U.S. biologics market, 2018 - 2030 (USD Billion)
FIG. 56 Canada biologics market, 2018 - 2030 (USD Billion)
FIG. 57 Europe biologics market, 2018 - 2030 (USD Billion)
FIG. 58 Germany biologics market, 2018 - 2030 (USD Billion)
FIG. 59 UK biologics market, 2018 - 2030 (USD Billion)
FIG. 60 France biologics market, 2018 - 2030 (USD Billion)
FIG. 61 Italy biologics market, 2018 - 2030 (USD Billion)
FIG. 62 Spain biologics market, 2018 - 2030 (USD Billion)
FIG. 63 Denmark biologics market, 2018 - 2030 (USD Billion)
FIG. 64 Sweden biologics market, 2018 - 2030 (USD Billion)
FIG. 65 Norway biologics market, 2018 - 2030 (USD Billion)
FIG. 66 Asia Pacific biologics market, 2018 - 2030 (USD Billion)
FIG. 67 Japan biologics market, 2018 - 2030 (USD Billion)
FIG. 68 China biologics market, 2018 - 2030 (USD Billion)
FIG. 69 India biologics market, 2018 - 2030 (USD Billion)
FIG. 70 Australia biologics market, 2018 - 2030 (USD Billion)
FIG. 71 South Korea biologics market, 2018 - 2030 (USD Billion)
FIG. 72 Thailand biologics market, 2018 - 2030 (USD Billion)
FIG. 73 Latin America biologics market, 2018 - 2030 (USD Billion)
FIG. 74 Brazil biologics market, 2018 - 2030 (USD Billion)
FIG. 75 Mexico biologics market, 2018 - 2030 (USD Billion)
FIG. 76 Argentina biologics market, 2018 - 2030 (USD Billion)
FIG. 77 Middle East & Africa biologics market, 2018 - 2030 (USD Billion)
FIG. 78 South Africa biologics market, 2018 - 2030 (USD Billion)
FIG. 79 Saudi Arabia biologics market, 2018 - 2030 (USD Billion)
FIG. 80 UAE biologics market, 2018 - 2030 (USD Billion)
FIG. 81 Kuwait biologics market, 2018 - 2030 (USD Billion)
FIG. 2 Market research process
FIG. 3 Information Procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain based sizing & forecasting
FIG. 7 QFD modelling for market share assessment
FIG. 8 Market summary
FIG. 9 Market trends & outlook
FIG. 10 Market segmentation & scope
FIG. 11 Market driver relevance analysis (Current & future impact)
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 Penetration & growth prospect mapping for Product, 2016
FIG. 14 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 15 Porter’s Five Forces Analysis
FIG. 16 Global biologics market: Source outlook key takeaways
FIG. 17 Global biologics market: Source movement analysis
FIG. 18 Global microbial source market, 2018 - 2030 (USD Billion)
FIG. 19 Global mammalian source market, 2018 - 2030 (USD Billion)
FIG. 20 Global other source market, 2018 - 2030 (USD Billion)
FIG. 21 Global biologics market: Product outlook key takeaways
FIG. 22 Global biologics market: Product movement analysis
FIG. 23 Global monoclonal antibodies market, 2018 - 2030 (USD Billion)
FIG. 24 Global diagnostic MABs market, 2018 - 2030 (USD Billion)
FIG. 25 Global diagnostic MABs for biochemical analysis market, 2018 - 2030 (USD Billion)
FIG. 26 Global diagnostic MABs for imaging market, 2018 - 2030 (USD Billion)
FIG. 27 Global therapeutic MABs market, 2018 - 2030 (USD Billion)
FIG. 28 Global direct MABs market, 2018 - 2030 (USD Billion)
FIG. 29 Global targeting MABs market, 2018 - 2030 (USD Billion)
FIG. 30 Global protein purification MABs market, 2018 - 2030 (USD Billion)
FIG. 31 Global other MABs market, 2018 - 2030 (USD Billion)
FIG. 32 Global murine MABs market, 2018 - 2030 (USD Billion)
FIG. 33 Global chimeric MABs market, 2018 - 2030 (USD Billion)
FIG. 34 Global humanized MABs market, 2018 - 2030 (USD Billion)
FIG. 35 Global human MABs market, 2018 - 2030 (USD Billion)
FIG. 36 Global other MABs market, 2018 - 2030 (USD Billion)
FIG. 37 Global vaccines market, 2018 - 2030 (USD Billion)
FIG. 38 Global recombinant proteins market, 2018 - 2030 (USD Billion)
FIG. 39 Global Antisense & RNAi Therapeutics market, 2018 - 2030 (USD Billion)
FIG. 40 Global other product market, 2018 - 2030 (USD Billion)
FIG. 41 Global biologics market: Manufacturing outlook key takeaways
FIG. 42 Global biologics market: Manufacturing movement analysis
FIG. 43 Global outsourced market, 2018 - 2030 (USD Billion)
FIG. 44 Global in-house market, 2018 - 2030 (USD Billion)
FIG. 45 Global biologics market: Disease category outlook key takeaways
FIG. 46 Global biologics market: Disease category movement analysis
FIG. 47 Global oncology market, 2018 - 2030 (USD Billion)
FIG. 48 Global infectious disease market, 2018 - 2030 (USD Billion)
FIG. 49 Global immunological disorders market, 2018 - 2030 (USD Billion)
FIG. 50 Global cardiovascular disorders market, 2018 - 2030 (USD Billion)
FIG. 51 Global hematologic disorders market, 2018 - 2030 (USD Billion)
FIG. 52 Global other indications market, 2018 - 2030 (USD Billion)
FIG. 53 Regional market place: Key takeaway
FIG. 54 North America biologics market, 2018 - 2030 (USD Billion)
FIG. 55 U.S. biologics market, 2018 - 2030 (USD Billion)
FIG. 56 Canada biologics market, 2018 - 2030 (USD Billion)
FIG. 57 Europe biologics market, 2018 - 2030 (USD Billion)
FIG. 58 Germany biologics market, 2018 - 2030 (USD Billion)
FIG. 59 UK biologics market, 2018 - 2030 (USD Billion)
FIG. 60 France biologics market, 2018 - 2030 (USD Billion)
FIG. 61 Italy biologics market, 2018 - 2030 (USD Billion)
FIG. 62 Spain biologics market, 2018 - 2030 (USD Billion)
FIG. 63 Denmark biologics market, 2018 - 2030 (USD Billion)
FIG. 64 Sweden biologics market, 2018 - 2030 (USD Billion)
FIG. 65 Norway biologics market, 2018 - 2030 (USD Billion)
FIG. 66 Asia Pacific biologics market, 2018 - 2030 (USD Billion)
FIG. 67 Japan biologics market, 2018 - 2030 (USD Billion)
FIG. 68 China biologics market, 2018 - 2030 (USD Billion)
FIG. 69 India biologics market, 2018 - 2030 (USD Billion)
FIG. 70 Australia biologics market, 2018 - 2030 (USD Billion)
FIG. 71 South Korea biologics market, 2018 - 2030 (USD Billion)
FIG. 72 Thailand biologics market, 2018 - 2030 (USD Billion)
FIG. 73 Latin America biologics market, 2018 - 2030 (USD Billion)
FIG. 74 Brazil biologics market, 2018 - 2030 (USD Billion)
FIG. 75 Mexico biologics market, 2018 - 2030 (USD Billion)
FIG. 76 Argentina biologics market, 2018 - 2030 (USD Billion)
FIG. 77 Middle East & Africa biologics market, 2018 - 2030 (USD Billion)
FIG. 78 South Africa biologics market, 2018 - 2030 (USD Billion)
FIG. 79 Saudi Arabia biologics market, 2018 - 2030 (USD Billion)
FIG. 80 UAE biologics market, 2018 - 2030 (USD Billion)
FIG. 81 Kuwait biologics market, 2018 - 2030 (USD Billion)
Companies Mentioned
- Samsung BioLogics
- Amgen
- Novo Nordisk A/S
- AbbVie Inc.
- Sanofi
- Johnson & Johnson Services, Inc
- Celltrion
- Bristol-Myers Squibb Company
- Eli Lilly and Company
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | May 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 461.74 Billion |
| Forecasted Market Value ( USD | $ 1009.37 Billion |
| Compound Annual Growth Rate | 10.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 9 |
